dr.s.nawaz limited Company Information
Company Number
07788308
Next Accounts
Dec 2025
Directors
Shareholders
shokat nawaz
shameem akhtar
Group Structure
View All
Industry
General medical practice activities
Registered Address
6 garden walk, rotherham, south yorkshire, S60 3HY
Website
-dr.s.nawaz limited Estimated Valuation
Pomanda estimates the enterprise value of DR.S.NAWAZ LIMITED at £317.3k based on a Turnover of £775.9k and 0.41x industry multiple (adjusted for size and gross margin).
dr.s.nawaz limited Estimated Valuation
Pomanda estimates the enterprise value of DR.S.NAWAZ LIMITED at £413.6k based on an EBITDA of £136.3k and a 3.03x industry multiple (adjusted for size and gross margin).
dr.s.nawaz limited Estimated Valuation
Pomanda estimates the enterprise value of DR.S.NAWAZ LIMITED at £1.6m based on Net Assets of £652.9k and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr.s.nawaz Limited Overview
Dr.s.nawaz Limited is a live company located in south yorkshire, S60 3HY with a Companies House number of 07788308. It operates in the general medical practice activities sector, SIC Code 86210. Founded in September 2011, it's largest shareholder is shokat nawaz with a 50% stake. Dr.s.nawaz Limited is a established, small sized company, Pomanda has estimated its turnover at £775.9k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dr.s.nawaz Limited Health Check
Pomanda's financial health check has awarded Dr.S.Nawaz Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs


3 Strong

2 Regular

5 Weak

Size
annual sales of £775.9k, make it smaller than the average company (£2m)
- Dr.s.nawaz Limited
£2m - Industry AVG

Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (10.5%)
- Dr.s.nawaz Limited
10.5% - Industry AVG

Production
with a gross margin of 20.4%, this company has a higher cost of product (39.5%)
- Dr.s.nawaz Limited
39.5% - Industry AVG

Profitability
an operating margin of 17.6% make it more profitable than the average company (3.7%)
- Dr.s.nawaz Limited
3.7% - Industry AVG

Employees
with 1 employees, this is below the industry average (23)
1 - Dr.s.nawaz Limited
23 - Industry AVG

Pay Structure
on an average salary of £34.6k, the company has an equivalent pay structure (£34.6k)
- Dr.s.nawaz Limited
£34.6k - Industry AVG

Efficiency
resulting in sales per employee of £775.9k, this is more efficient (£87.3k)
- Dr.s.nawaz Limited
£87.3k - Industry AVG

Debtor Days
it gets paid by customers after 146 days, this is later than average (30 days)
- Dr.s.nawaz Limited
30 days - Industry AVG

Creditor Days
its suppliers are paid after 27 days, this is close to average (25 days)
- Dr.s.nawaz Limited
25 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Dr.s.nawaz Limited
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Dr.s.nawaz Limited
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 7%, this is a lower level of debt than the average (56.3%)
7% - Dr.s.nawaz Limited
56.3% - Industry AVG
DR.S.NAWAZ LIMITED financials

Dr.S.Nawaz Limited's latest turnover from March 2024 is estimated at £775.9 thousand and the company has net assets of £652.9 thousand. According to their latest financial statements, Dr.S.Nawaz Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||
Other Income Or Grants | |||||||||||||
Cost Of Sales | |||||||||||||
Gross Profit | |||||||||||||
Admin Expenses | |||||||||||||
Operating Profit | |||||||||||||
Interest Payable | |||||||||||||
Interest Receivable | |||||||||||||
Pre-Tax Profit | |||||||||||||
Tax | |||||||||||||
Profit After Tax | |||||||||||||
Dividends Paid | |||||||||||||
Retained Profit | |||||||||||||
Employee Costs | |||||||||||||
Number Of Employees | 1 | 1 | 1 | 2 | 1 | 1 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 390,853 | 185,952 | 186,074 | 822 | 1,003 | 1,223 | 1,492 | 1,820 | 55,777 | 2,706 | 8,596 | 10,483 | 12,285 |
Intangible Assets | |||||||||||||
Investments & Other | |||||||||||||
Debtors (Due After 1 year) | 19,956 | 20,453 | 36,390 | ||||||||||
Total Fixed Assets | 390,853 | 185,952 | 186,074 | 822 | 1,003 | 1,223 | 1,492 | 1,820 | 75,733 | 23,159 | 44,986 | 10,483 | 12,285 |
Stock & work in progress | |||||||||||||
Trade Debtors | 310,758 | 408,512 | 280,524 | 355,296 | 217,759 | 122,381 | 44,333 | 26,930 | 36,082 | 14,308 | |||
Group Debtors | |||||||||||||
Misc Debtors | |||||||||||||
Cash | 29,886 | 6,106 | 494 | 20,191 | 38,368 | ||||||||
misc current assets | |||||||||||||
total current assets | 310,758 | 408,512 | 280,524 | 355,296 | 217,759 | 122,381 | 44,333 | 26,930 | 29,886 | 6,106 | 494 | 56,273 | 52,676 |
total assets | 701,611 | 594,464 | 466,598 | 356,118 | 218,762 | 123,604 | 45,825 | 28,750 | 105,619 | 29,265 | 45,480 | 66,756 | 64,961 |
Bank overdraft | |||||||||||||
Bank loan | |||||||||||||
Trade Creditors | 45,844 | 37,553 | 37,573 | 38,640 | 26,432 | 19,723 | 6,188 | 16,352 | 4,352 | 11,725 | 22,403 | 12,972 | |
Group/Directors Accounts | |||||||||||||
other short term finances | 1,892 | ||||||||||||
hp & lease commitments | |||||||||||||
other current liabilities | |||||||||||||
total current liabilities | 45,844 | 37,553 | 37,573 | 38,640 | 26,432 | 19,723 | 6,188 | 1,892 | 16,352 | 4,352 | 11,725 | 22,403 | 12,972 |
loans | |||||||||||||
hp & lease commitments | |||||||||||||
Accruals and Deferred Income | 263 | 250 | |||||||||||
other liabilities | 2,633 | 5,992 | 46,208 | ||||||||||
provisions | |||||||||||||
total long term liabilities | 2,896 | 6,242 | 46,208 | ||||||||||
total liabilities | 48,740 | 43,795 | 37,573 | 38,640 | 26,432 | 19,723 | 6,188 | 1,892 | 62,560 | 4,352 | 11,725 | 22,403 | 12,972 |
net assets | 652,871 | 550,669 | 429,025 | 317,478 | 192,330 | 103,881 | 39,637 | 26,858 | 43,059 | 24,913 | 33,755 | 44,353 | 51,989 |
total shareholders funds | 652,871 | 550,669 | 429,025 | 317,478 | 192,330 | 103,881 | 39,637 | 26,858 | 43,059 | 24,913 | 33,755 | 44,353 | 51,989 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||
Operating Profit | |||||||||||||
Depreciation | 3,306 | 1,479 | 1,887 | 2,302 | 3,071 | ||||||||
Amortisation | |||||||||||||
Tax | |||||||||||||
Stock | |||||||||||||
Debtors | -97,754 | 127,988 | -74,772 | 137,537 | 95,378 | 78,048 | 17,403 | 6,974 | -497 | -15,937 | 308 | 21,774 | 14,308 |
Creditors | 8,291 | -20 | -1,067 | 12,208 | 6,709 | 13,535 | 6,188 | -16,352 | 12,000 | -7,373 | -10,678 | 9,431 | 12,972 |
Accruals and Deferred Income | 13 | 250 | |||||||||||
Deferred Taxes & Provisions | |||||||||||||
Cash flow from operations | |||||||||||||
Investing Activities | |||||||||||||
capital expenditure | |||||||||||||
Change in Investments | |||||||||||||
cash flow from investments | |||||||||||||
Financing Activities | |||||||||||||
Bank loans | |||||||||||||
Group/Directors Accounts | |||||||||||||
Other Short Term Loans | -1,892 | 1,892 | |||||||||||
Long term loans | |||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||
other long term liabilities | -3,359 | 5,992 | -46,208 | 46,208 | |||||||||
share issue | |||||||||||||
interest | |||||||||||||
cash flow from financing | |||||||||||||
cash and cash equivalents | |||||||||||||
cash | -29,886 | 23,780 | 5,612 | -19,697 | -18,177 | 38,368 | |||||||
overdraft | |||||||||||||
change in cash | -29,886 | 23,780 | 5,612 | -19,697 | -18,177 | 38,368 |
dr.s.nawaz limited Credit Report and Business Information
Dr.s.nawaz Limited Competitor Analysis

Perform a competitor analysis for dr.s.nawaz limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in S60 area or any other competitors across 12 key performance metrics.
dr.s.nawaz limited Ownership
DR.S.NAWAZ LIMITED group structure
Dr.S.Nawaz Limited has no subsidiary companies.
Ultimate parent company
DR.S.NAWAZ LIMITED
07788308
dr.s.nawaz limited directors
Dr.S.Nawaz Limited currently has 1 director, Shokat Nawaz serving since Sep 2011.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Shokat Nawaz | United Kingdom | 57 years | Sep 2011 | - | Director |
P&L
March 2024turnover
775.9k
-5%
operating profit
136.3k
0%
gross margin
20.4%
-1.49%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
652.9k
+0.19%
total assets
701.6k
+0.18%
cash
0
0%
net assets
Total assets minus all liabilities
dr.s.nawaz limited company details
company number
07788308
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
September 2011
age
14
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
GRIFFIN CONSULTANTS LIMITED
auditor
-
address
6 garden walk, rotherham, south yorkshire, S60 3HY
Bank
-
Legal Advisor
-
dr.s.nawaz limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dr.s.nawaz limited.
dr.s.nawaz limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DR.S.NAWAZ LIMITED. This can take several minutes, an email will notify you when this has completed.
dr.s.nawaz limited Companies House Filings - See Documents
date | description | view/download |
---|